Investors

Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain.

Shareholder Information

Date Title Document
22/05/23 Notice of 2023 AGM Download
08/03/23 FAQs and Transfer Form regarding proposed AIM cancellation Download
08/03/23 Shareholder Circular and Notice of General Meeting to be held on 24 March 2023 Download
06/01/23 Shareholder Circular and Notice of General Meeting to be held on 23 January 2023 Download
23/05/22 Notice of 2022 AGM Download
21/05/21 Notice of 2021 AGM Download
08/12/20 Notice of 2020 AGM Download
12/02/20 Shareholder Circular and Notice of General Meeting to be held on 2 March 20 Download
19/06/19 Notice of 2019 AGM Download
05/02/19 Shareholder Circular, Open Offer & Notice of General Meeting Panel Waiver Download
28/09/18 Shareholder Circular and Notice of General Meeting to be held on 15 October 18 Download
13/08/18 Notice of 2018 AGM Download
28/09/17 Notice of General Meeting to be held on 16 October 2017 Download
11/04/17 Notice of Annual General Meeting 2017 Download
12/10/16 Notice of General Meeting to be held on 28 October 2016 Download
11/05/16 Notice of 2016 AGM Download
21/05/15 Notice of 2015 AGM Download

Share Detail

Number of shares 96,679,412
Country of listing US
Status NASDAQ Listed
Index NASDAQ
Tickers NASDAQ:BDRX
CUSIP 59564R609

The percentage of 2p Ordinary shares not being held in public hands is 0.07%

Shares held in treasury: Nil.

There are no restrictions on the transfer of Ordinary shares in the Company.

Information correct as of 11 May 2023.

ADR Information

Ticker Structure Exchange Ratio DR ISIN CUSIP
BDRX Level III ADR NASDAQ 1 ADR : 5 Ordinary Shares US59564R6099 59564R609